17 bills in the Illinois legislature name the 340B program. Two became law. Here is what each one is, how far it has got and where to read it.
104th Regular Session
Runs to 12 January 2027
About 340B
Contract pharmacy access
Reporting
Study
Other
HB 2371DENTAL INSURANCE ASSIGNABILITY
Bars drug makers from limiting the purchase or delivery of 340B drugs to covered entities and their contract pharmacies. Covered entities must report 340B figures to lawmakers yearly, keep a policy against duplicate discounts and dispense 340B drugs only for outpatient care in the last 18 months.
Became law7 August 2026
Latest step
7 August 2026: Public Act . . . . . . . . . 104-0758
Sponsor
Anna Moeller; David Koehler, with 30 cosponsors
Introduced
31 January 2025
Where it names 340B: HB 2371
… finds that: (1) It is within the traditional authority of the State to regulate the acquisition and delivery of drugs to pharmacies and providers. (2) The federal 340B statute is silent on distribution of 340B-acquired drugs to 340B covered entities and their contract pharmacy partners. (3) The State's compelling interest in …
Orders the state insurance department to study how covered entities and drug makers take part in 340B and to report its findings by July 1, 2028. Covered entities and drug makers must supply the figures it asks for or face daily fines.
Became law7 August 2026
Latest step
7 August 2026: Public Act . . . . . . . . . 104-0769
Sponsor
Camille Y. Lilly; David Koehler, with 38 cosponsors
Introduced
7 January 2026
Where it names 340B: HB 4327
… ACT concerning auditing. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section 1. Short title. This Act may be cited as the 340B Transparency, Reporting, and Accountability Act. Section 5. Findings. The General Assembly finds that: (1) The intent of the 340B Drug Discount Program is to provide …
A House resolution that would direct the state Auditor General to investigate how covered entities use 340B, including 340B profit, payments to contract pharmacies and whether discounts reach patients, and the effect on Medicaid and the state employee health plan.
Introduced26 February 2025
Latest step
1 July 2026: Rule 19(b) / Re-referred to Rules Committee
Sponsor
Curtis J. Tarver, II, with 22 cosponsors
Where it names 340B: HR 158
… Illinois General Assembly ILGA.GOV HR0158 - 104th General Assembly (2025-2026) HR0158 LRB104 12436 ECR 22753 r HOUSE RESOLUTION WHEREAS, The original intent of the 340B Drug Pricing Program was to provide discounted medicines to eligible healthcare organizations for the purpose of improving access to affordable medications for …
Would require covered entities to report each year to the state health department on 340B drug costs, payments received, payments to contract pharmacies and use of savings, with a combined public report. Would also say drug makers may ask covered entities for dispensing data.
Introduced4 February 2026
Latest step
13 April 2026: Added Co-Sponsor Rep. Joyce Mason
Sponsor
Martha Deuter, with 1 cosponsor
Where it names 340B: HB 4954
… Assembly (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 HB4954 Introduced , by Rep. Martha Deuter SYNOPSIS AS INTRODUCED: New Act Creates the 340B Drug Pricing Program Reporting Act. On or before April 1, 2027 and each April 1 thereafter, requires a 340B covered entity to report the specified information and …
Would bar drug makers and others from denying or limiting the purchase of 340B drugs by grantee covered entities, or by contract pharmacies in the state acting for them, unless federal law prohibits it. A state department would enforce it.
Introduced22 May 2025
Latest step
27 March 2026: House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee
Sponsor
Rita Mayfield, with 4 cosponsors
Where it names 340B: HB 4065
… (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 HB4065 Introduced 5/22/2025, by Rep. Rita Mayfield SYNOPSIS AS INTRODUCED: New Act Creates the 340B Grantee Contract Pharmacy Access Act. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, or otherwise limit the acquisition of a 340B …
Would require covered entities to report each year to the state health department on 340B drug costs, payments received, payments to contract pharmacies and use of savings, with a combined public report. Would also say drug makers may ask covered entities for dispensing data.
Introduced2 February 2026
Latest step
27 March 2026: Rule 3-9(a) / Re-referred to Assignments
Sponsor
Adriane L. Johnson, with 1 cosponsor
Where it names 340B: SB 3146
… (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB3146 Introduced 2/2/2026, by Sen. Christopher Belt SYNOPSIS AS INTRODUCED: New Act Creates the 340B Drug Pricing Program Reporting Act. On or before April 1, 2027 and each April 1 thereafter, requires a 340B covered entity to report the specified information and …
Would bar covered entities from billing Medicaid for 340B drugs, require them to use 80% of 340B profits to lower what low-income patients pay for those drugs, and require yearly reports posted publicly. Would also order state reports on 340B in Medicaid and the state employee plan.
Introduced6 February 2026
Latest step
13 February 2026: Referred to Rules Committee
Sponsor
Bob Morgan
Where it names 340B: HB 5421
… Assembly (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 HB5421 Introduced 2/13/2026, by Rep. Bob Morgan SYNOPSIS AS INTRODUCED: New Act Creates the 340B Integrity Act. Defines terms. Provides that, beginning January 1, 2027, 340B covered entities shall not bill any medical assistance fee-for-service or medical …
Would bar covered entities from billing Medicaid for 340B drugs, require them to use 80% of 340B profits to lower what low-income patients pay for those drugs, and require yearly reports posted publicly. Would also order state reports on 340B in Medicaid and the state employee plan.
Introduced6 February 2026
Latest step
6 February 2026: Referred to Assignments
Sponsor
Julie A. Morrison
Where it names 340B: SB 3878
… (2025-2026) 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB3878 Introduced 2/6/2026, by Sen. Julie A. Morrison SYNOPSIS AS INTRODUCED: New Act Creates the 340B Integrity Act. Defines terms. Provides that, beginning January 1, 2027, 340B covered entities shall not bill any medical assistance fee-for-service or medical …
Would bar drug makers from limiting the purchase or delivery of 340B drugs to covered entities and their contract pharmacies, from restricting which contract pharmacies an entity uses, and from requiring pricing or other data as a condition. A state department would enforce it.
Introduced7 February 2025
Latest step
2 June 2025: Rule 3-9(a) / Re-referred to Assignments
Sponsor
David Koehler, with 26 cosponsors
Where it names 340B: SB 2385
… including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless …
Would bar drug makers from limiting the purchase or delivery of 340B drugs to covered entities and their contract pharmacies, from restricting which contract pharmacies an entity uses, and from requiring pricing or other data as a condition. A state department would enforce it.
Introduced7 February 2025
Latest step
24 April 2025: Added Co-Sponsor Rep. Elizabeth "Lisa" Hernandez
Sponsor
Anna Moeller, with 24 cosponsors
Where it names 340B: HB 3350
… including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless …
In a wider bill to create a prescription drug affordability board, would require the board to examine how an upper limit on what is paid for a drug would affect 340B covered entities.
Reported by committee16 April 2026
Latest step
17 April 2026: House Floor Amendment No. 3 Rule 19(c) / Re-referred to Rules Committee
Sponsor
Nabeela Syed, with 29 cosponsors
Introduced
17 January 2025
Where it names 340B: HB 1443
… 30. Protections and other Board considerations. (a) The Board shall examine how an upper payment limit would affect a covered entity, as that term is defined in Section 340B of the federal Public Health Service Act. (b) In determining whether a drug creates an affordability challenge or determining an upper payment limit amount, the Board …
In a wider bill creating a board that could set upper payment limits on prescription drugs, would require the board to examine how such a limit would affect 340B covered entities.
Introduced13 January 2025
Latest step
22 May 2026: Senate Committee Amendment No. 4 Rule 3-9(a) / Re-referred to Assignments
Sponsor
Graciela Guzmán, with 18 cosponsors
Where it names 340B: SB 66
… 30. Protections and other Board considerations. (a) The Board shall examine how an upper payment limit would affect a covered entity, as that term is defined in Section 340B of the federal Public Health Service Act. (b) In determining whether a drug creates an affordability challenge or determining an upper payment limit amount, the Board …
An amendment filed to this bill would amend the pharmacy benefit manager law. The amended sections carry a bar, for contracts after July 1, 2022, on terms that pay 340B entities or their pharmacies less or add fees because of 340B, and have Medicaid managed care plans pay 340B pharmacy claims.
Introduced24 January 2025
Latest step
2 June 2025: Rule 3-9(a) / Re-referred to Assignments
Sponsor
David Koehler, with 6 cosponsors
Where it names 340B: SB 709
… 10400SB0709sam001 - 5 - LRB104 07007 BAB 24876 a 513b1.1 as follows: (215 ILCS 5/513b1) Sec. 513b1. Pharmacy benefit manager contracts. (a) As used in this Section: "340B drug discount program" means the program established under Section 340B of the federal Public Health Service Act, 42 U.S.C. 256b. "340B entity" means a covered entity …
From an amendment filed to the bill. The bill’s own newest text does not name 340B.
An amendment filed to this bill would amend the pharmacy benefit manager law. The amended sections carry a bar, for contracts after July 1, 2022, on terms that pay 340B entities or their pharmacies less or add fees because of 340B, and have Medicaid managed care plans pay 340B pharmacy claims.
Introduced29 January 2025
Latest step
2 June 2025: Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments
Sponsor
David Koehler, with 3 cosponsors
Where it names 340B: SB 1390
… 10400SB1390sam001 - 5 - LRB104 08735 BAB 23976 a 513b1.1 as follows: (215 ILCS 5/513b1) Sec. 513b1. Pharmacy benefit manager contracts. (a) As used in this Section: "340B drug discount program" means the program established under Section 340B of the federal Public Health Service Act, 42 U.S.C. 256b. "340B entity" means a covered entity …
From an amendment filed to the bill. The bill’s own newest text does not name 340B.